AltStreet
EDGAR Verified
Primary Source · SEC.gov

CCA LONGEVITY FUND IV (US II), LLC

CIK 0001938426Fund Vehicle2023 vintage506(b), 3(c)

Raised

$48M

Investors

90

Min Invest

$250,000

AltStreet Analysis

·

Generated from EDGAR primary sources

CCA Longevity Fund IV (US II), LLC is a Delaware pooled investment fund that has raised $48.2M from 90 investors under Rule 506(b) and Section 3(c) exemptions, with a $250K minimum investment. This is an amended filing with William Corry listed as director. The fund operates as a standalone longevity and biotech-focused vehicle.

This longevity/biotech fund employs the standard 506(b) private placement exemption with a $250K minimum, positioning it in the accessible-HNW tier rather than institutional-only territory. The 90-investor count against $48.2M raised suggests an average commitment of approximately $536K, typical for specialized life sciences funds targeting accredited individuals and family offices.

Data Flags

generalRelatively high investor count (90) for the capital raised ($48.2M), indicating average check size of ~$536K, only slightly above the stated minimum of $250K
sales_commissionsNo sales commissions stated on a $48.2M raise across 90 investors, suggesting direct distribution rather than broker-dealer channels

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0001938426
Entity NameCCA LONGEVITY FUND IV (US II), LLC
Exemption506(b), 3(c)
First Sale Date—
Filing DateMarch 1, 2023
Accession Number0001938426-23-000001
Total Amount Sold$48M
Total Investors90
Minimum Investment$250,000
Securities TypePooled Investment Fund
State of IncorporationNot specified
Amendment CountOriginal filing only

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

William Corry

Director · Vero Beach, FL

Is this your offering?

Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.

Claim Profile — FreeGet Verified — $2,400/yr

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.